logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10117926 B1

PDFFull Text
Date of Patent:
Nov. 06, 2018

Filed:

Jun. 29, 2016

Respiratory syncytial virus vaccine

Applicants:

Vib Vzw, Ghent, BE;

Universiteit Gent, Ghent, BE;

Inventors:

Xavier Saelens, Ieper, BE;

Bert Schepens, Ghent, BE;

Walter Fiers, Destelbergen, BE;

Assignees:

VIB VZW, Ghent, BE;

UNIVERSITEIT GENT, Ghent, BE;

Attorneys:

Lathrop Gage LLP

James H. Velema, Esq.

Primary Examiner:

Shanon A Foley

Assistant Examiner:

Myron G Hill

Int. Cl.
CPC ...
A61K 39/155 (2006.01); A61K 39/12 (2006.01); C07K 16/10 (2006.01); C12N 7/02 (2006.01); C07K 7/06 (2006.01); C07K 14/005 (2006.01); C07K 14/78 (2006.01); A61K 39/385 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/155 (2013.01); A61K 39/12 (2013.01); A61K 39/385 (2013.01); C07K 7/06 (2013.01); C07K 14/005 (2013.01); C07K 14/78 (2013.01); C07K 16/1027 (2013.01); C12N 7/00 (2013.01); C12N 7/02 (2013.01); A61K 2039/5258 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55544 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6075 (2013.01); A61K 2039/6081 (2013.01); A61K 2039/645 (2013.01); C07K 2317/10 (2013.01); C07K 2317/76 (2013.01); C12N 2760/18522 (2013.01); C12N 2760/18534 (2013.01); C12N 2760/18571 (2013.01);
Abstract

Described is a vaccine against Respiratory Syncytial Virus (RSV). More specifically, described is a recombinant subunit vaccine comprising the ectodomain of the RSV-encoded Small Hydrophobic (SH) protein. The ectodomain of SH is referred to as SHe. The ectodomain is typically presented as an oligomer, or pentamer. Further described are antibodies, raised against the ectodomain or specific for the ectodomain, and their use for protecting a subject against RSV infection and/or for treatment of an infected subject.

Find Patent Forward Citations

Saelens, Xavier. (2018). Respiratory syncytial virus vaccine (U.S. Patent No. 10117926). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10117926

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…